AAAAAA

   
Results: 1-9 |
Results: 9
Psoriasis - Immunopathology and immunomodulation
Authors: Gottlieb, AB
Citation: Ab. Gottlieb, Psoriasis - Immunopathology and immunomodulation, DERM CLIN, 19(4), 2001, pp. 649
Consensus conference: Acitretin in combination with UVB or PUVA in the treatment of psoriasis
Authors: Lebwohl, M Drake, L Menter, A Koo, J Gottlieb, AB Zanolli, M Young, M McClelland, P
Citation: M. Lebwohl et al., Consensus conference: Acitretin in combination with UVB or PUVA in the treatment of psoriasis, J AM ACAD D, 45(4), 2001, pp. 544-553
Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: arandomised trial
Authors: Chaudhari, U Romano, P Mulcahy, LD Dooley, LT Baker, DG Gottlieb, AB
Citation: U. Chaudhari et al., Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: arandomised trial, LANCET, 357(9271), 2001, pp. 1842-1847
Concomitant administration of vitamin E does not change the side effects of isotretinoin as used in acne vulgaris: A randomized trial
Authors: Strauss, JS Gottlieb, AB Jones, T Koo, JYM Leyden, JJ Lucky, A Pappas, AA McLane, J Leach, EE
Citation: Js. Strauss et al., Concomitant administration of vitamin E does not change the side effects of isotretinoin as used in acne vulgaris: A randomized trial, J AM ACAD D, 43(5), 2000, pp. 777-784
Anti-CD4 monoclonal antibody treatment of moderate to severe psoriasis vulgaris: Results of a pilot, multicenter, multiple-dose, placebo-controlled study
Authors: Gottlieb, AB Lebwohl, M Shirin, S Sherr, A Gilleaudeau, P Singer, G Solodkina, G Grossman, R Gisoldi, E Phillips, S Neisler, M Krueger, JG
Citation: Ab. Gottlieb et al., Anti-CD4 monoclonal antibody treatment of moderate to severe psoriasis vulgaris: Results of a pilot, multicenter, multiple-dose, placebo-controlled study, J AM ACAD D, 43(4), 2000, pp. 595-604
Successful in vivo blockade of CD25 (high-affinity interleukin 2 receptor)on T cells by administration of humanized anti-Tac antibody to patients with psoriasis
Authors: Krueger, JG Walters, IB Miyazawa, M Gilleaudeau, P Hakimi, J Light, S Sherr, A Gottlieb, AB
Citation: Jg. Krueger et al., Successful in vivo blockade of CD25 (high-affinity interleukin 2 receptor)on T cells by administration of humanized anti-Tac antibody to patients with psoriasis, J AM ACAD D, 43(3), 2000, pp. 448-458
Two considerations for patients with psoriasis and their clinicians: What defines mild, moderate, and severe psoriasis? What constitutes a clinicallysignificant improvement when treating psoriasis?
Authors: Krueger, GG Feldman, SR Camisa, C Duvic, M Elder, JT Gottlieb, AB Koo, J Krueger, JG Lebwohl, M Lowe, N Menter, A Morison, WL Prystowsky, JH Shupack, JL Taylor, JR Weinstein, GD Barton, TL Rolstad, T Day, RM
Citation: Gg. Krueger et al., Two considerations for patients with psoriasis and their clinicians: What defines mild, moderate, and severe psoriasis? What constitutes a clinicallysignificant improvement when treating psoriasis?, J AM ACAD D, 43(2), 2000, pp. 281-285
Treatment with anti-tumor necrosis factor alpha (TNF-alpha) monoclonal antibody dramatically decreases the clinical activity of psoriasis lesions
Authors: Oh, CJ Das, KM Gottlieb, AB
Citation: Cj. Oh et al., Treatment with anti-tumor necrosis factor alpha (TNF-alpha) monoclonal antibody dramatically decreases the clinical activity of psoriasis lesions, J AM ACAD D, 42(5), 2000, pp. 829-830
Staphylococcal scalded skin syndrome in an immunocompetent adult: Possibleimplication of low-dosage prednisone
Authors: Shirin, S Gottlieb, AB Stahl, EB
Citation: S. Shirin et al., Staphylococcal scalded skin syndrome in an immunocompetent adult: Possibleimplication of low-dosage prednisone, CUTIS, 62(5), 1998, pp. 223-224
Risultati: 1-9 |